TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Type-1 Diabetes Treatment Market Research Report 2023

Global Type-1 Diabetes Treatment Market Research Report 2023

  • Category:Life Sciences
  • Published on : 15 February 2023
  • Pages :90
  • Formats:
  • Report Code:SMR-7567860

Market Analysis and Insights: Global Type1 Diabetes Treatment Market

The global Type1 Diabetes Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Type1 Diabetes Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Type1 Diabetes Treatment market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Type1 Diabetes Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Type1 Diabetes Treatment market.

Global Type1 Diabetes Treatment Scope and Market Size

Type-1 Diabetes Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Type-1 Diabetes Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2032.
Segment by Type
Rapid-Acting Insulin
Short-Acting Insulin
Others
Segment by Application
Hospitals & Clinics
Academic & Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Astellas Pharma
Merck
Eli Lilly
Novo Nordisk
Sanofi
AstraZeneca
Boehringer Ingelheim GmbH
Novartis
Pfizer Inc.
Abbott Laboratories
Mannkind Corporation
Braun Melsungen AG
Macrogenics, Inc.

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Type1 Diabetes Treatment product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Type1 Diabetes Treatment, with price, sales, revenue, and global market share of Type1 Diabetes Treatment from 2019 to 2022.

Chapter 3, the Type1 Diabetes Treatment competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Type1 Diabetes Treatment breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Type1 Diabetes Treatment market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Type1 Diabetes Treatment.

Chapter 13, 14, and 15, to describe Type1 Diabetes Treatment sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Type1 Diabetes Treatment Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

TABLE OF CONTENTS

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Type-1 Diabetes Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2032
1.2.2 Rapid-Acting Insulin
1.2.3 Short-Acting Insulin
1.2.4 Others
1.3 Market by Application
1.3.1 Global Type-1 Diabetes Treatment Market Share by Application: 2018 VS 2022 VS 2032
1.3.2 Hospitals & Clinics
1.3.3 Academic & Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Type-1 Diabetes Treatment Market Perspective (2018-2032)
2.2 Type-1 Diabetes Treatment Growth Trends by Region
2.2.1 Type-1 Diabetes Treatment Market Size by Region: 2018 VS 2022 VS 2032
2.2.2 Type-1 Diabetes Treatment Historic Market Size by Region (2018-2023)
2.2.3 Type-1 Diabetes Treatment Forecasted Market Size by Region (2023-2032)
2.3 Type-1 Diabetes Treatment Market Dynamics
2.3.1 Type-1 Diabetes Treatment Industry Trends
2.3.2 Type-1 Diabetes Treatment Market Drivers
2.3.3 Type-1 Diabetes Treatment Market Challenges
2.3.4 Type-1 Diabetes Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Type-1 Diabetes Treatment Players by Revenue
3.1.1 Global Top Type-1 Diabetes Treatment Players by Revenue (2018-2023)
3.1.2 Global Type-1 Diabetes Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Type-1 Diabetes Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Type-1 Diabetes Treatment Revenue
3.4 Global Type-1 Diabetes Treatment Market Concentration Ratio
3.4.1 Global Type-1 Diabetes Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Type-1 Diabetes Treatment Revenue in 2022
3.5 Type-1 Diabetes Treatment Key Players Head office and Area Served
3.6 Key Players Type-1 Diabetes Treatment Product Solution and Service
3.7 Date of Enter into Type-1 Diabetes Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Type-1 Diabetes Treatment Breakdown Data by Type
4.1 Global Type-1 Diabetes Treatment Historic Market Size by Type (2018-2023)
4.2 Global Type-1 Diabetes Treatment Forecasted Market Size by Type (2023-2032)
5 Type-1 Diabetes Treatment Breakdown Data by Application
5.1 Global Type-1 Diabetes Treatment Historic Market Size by Application (2018-2023)
5.2 Global Type-1 Diabetes Treatment Forecasted Market Size by Application (2023-2032)
6 North America
6.1 North America Type-1 Diabetes Treatment Market Size (2018-2032)
6.2 North America Type-1 Diabetes Treatment Market Size by Country (2018-2023)
6.3 North America Type-1 Diabetes Treatment Market Size by Country (2023-2032)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Type-1 Diabetes Treatment Market Size (2018-2032)
7.2 Europe Type-1 Diabetes Treatment Market Size by Country (2018-2023)
7.3 Europe Type-1 Diabetes Treatment Market Size by Country (2023-2032)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Type-1 Diabetes Treatment Market Size (2018-2032)
8.2 Asia-Pacific Type-1 Diabetes Treatment Market Size by Country (2018-2023)
8.3 Asia-Pacific Type-1 Diabetes Treatment Market Size by Country (2023-2032)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Type-1 Diabetes Treatment Market Size (2018-2032)
9.2 Latin America Type-1 Diabetes Treatment Market Size by Country (2018-2023)
9.3 Latin America Type-1 Diabetes Treatment Market Size by Country (2023-2032)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Type-1 Diabetes Treatment Market Size (2018-2032)
10.2 Middle East & Africa Type-1 Diabetes Treatment Market Size by Country (2018-2023)
10.3 Middle East & Africa Type-1 Diabetes Treatment Market Size by Country (2023-2032)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Detail
11.1.2 Astellas Pharma Business Overview
11.1.3 Astellas Pharma Type-1 Diabetes Treatment Introduction
11.1.4 Astellas Pharma Revenue in Type-1 Diabetes Treatment Business (2018-2023)
11.1.5 Astellas Pharma Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Type-1 Diabetes Treatment Introduction
11.2.4 Merck Revenue in Type-1 Diabetes Treatment Business (2018-2023)
11.2.5 Merck Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Detail
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Type-1 Diabetes Treatment Introduction
11.3.4 Eli Lilly Revenue in Type-1 Diabetes Treatment Business (2018-2023)
11.3.5 Eli Lilly Recent Development
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Detail
11.4.2 Novo Nordisk Business Overview
11.4.3 Novo Nordisk Type-1 Diabetes Treatment Introduction
11.4.4 Novo Nordisk Revenue in Type-1 Diabetes Treatment Business (2018-2023)
11.4.5 Novo Nordisk Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Detail
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Type-1 Diabetes Treatment Introduction
11.5.4 Sanofi Revenue in Type-1 Diabetes Treatment Business (2018-2023)
11.5.5 Sanofi Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Detail
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Type-1 Diabetes Treatment Introduction
11.6.4 AstraZeneca Revenue in Type-1 Diabetes Treatment Business (2018-2023)
11.6.5 AstraZeneca Recent Development
11.7 Boehringer Ingelheim GmbH
11.7.1 Boehringer Ingelheim GmbH Company Detail
11.7.2 Boehringer Ingelheim GmbH Business Overview
11.7.3 Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Introduction
11.7.4 Boehringer Ingelheim GmbH Revenue in Type-1 Diabetes Treatment Business (2018-2023)
11.7.5 Boehringer Ingelheim GmbH Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Type-1 Diabetes Treatment Introduction
11.8.4 Novartis Revenue in Type-1 Diabetes Treatment Business (2018-2023)
11.8.5 Novartis Recent Development
11.9 Pfizer Inc.
11.9.1 Pfizer Inc. Company Detail
11.9.2 Pfizer Inc. Business Overview
11.9.3 Pfizer Inc. Type-1 Diabetes Treatment Introduction
11.9.4 Pfizer Inc. Revenue in Type-1 Diabetes Treatment Business (2018-2023)
11.9.5 Pfizer Inc. Recent Development
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Company Detail
11.10.2 Abbott Laboratories Business Overview
11.10.3 Abbott Laboratories Type-1 Diabetes Treatment Introduction
11.10.4 Abbott Laboratories Revenue in Type-1 Diabetes Treatment Business (2018-2023)
11.10.5 Abbott Laboratories Recent Development
11.11 Mannkind Corporation
11.11.1 Mannkind Corporation Company Detail
11.11.2 Mannkind Corporation Business Overview
11.11.3 Mannkind Corporation Type-1 Diabetes Treatment Introduction
11.11.4 Mannkind Corporation Revenue in Type-1 Diabetes Treatment Business (2018-2023)
11.11.5 Mannkind Corporation Recent Development
11.12 Braun Melsungen AG
11.12.1 Braun Melsungen AG Company Detail
11.12.2 Braun Melsungen AG Business Overview
11.12.3 Braun Melsungen AG Type-1 Diabetes Treatment Introduction
11.12.4 Braun Melsungen AG Revenue in Type-1 Diabetes Treatment Business (2018-2023)
11.12.5 Braun Melsungen AG Recent Development
11.13 Macrogenics, Inc.
11.13.1 Macrogenics, Inc. Company Detail
11.13.2 Macrogenics, Inc. Business Overview
11.13.3 Macrogenics, Inc. Type-1 Diabetes Treatment Introduction
11.13.4 Macrogenics, Inc. Revenue in Type-1 Diabetes Treatment Business (2018-2023)
11.13.5 Macrogenics, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Type-1 Diabetes Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2032
Table 2. Key Players of Rapid-Acting Insulin
Table 3. Key Players of Short-Acting Insulin
Table 4. Key Players of Others
Table 5. Global Type-1 Diabetes Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2032
Table 6. Global Type-1 Diabetes Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2032
Table 7. Global Type-1 Diabetes Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Type-1 Diabetes Treatment Market Share by Region (2018-2023)
Table 9. Global Type-1 Diabetes Treatment Forecasted Market Size by Region (2023-2032) & (US$ Million)
Table 10. Global Type-1 Diabetes Treatment Market Share by Region (2023-2032)
Table 11. Type-1 Diabetes Treatment Market Trends
Table 12. Type-1 Diabetes Treatment Market Drivers
Table 13. Type-1 Diabetes Treatment Market Challenges
Table 14. Type-1 Diabetes Treatment Market Restraints
Table 15. Global Type-1 Diabetes Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Type-1 Diabetes Treatment Market Share by Players (2018-2023)
Table 17. Global Top Type-1 Diabetes Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type-1 Diabetes Treatment as of 2022)
Table 18. Ranking of Global Top Type-1 Diabetes Treatment Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Type-1 Diabetes Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Type-1 Diabetes Treatment Product Solution and Service
Table 22. Date of Enter into Type-1 Diabetes Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Type-1 Diabetes Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Type-1 Diabetes Treatment Revenue Market Share by Type (2018-2023)
Table 26. Global Type-1 Diabetes Treatment Forecasted Market Size by Type (2023-2032) & (US$ Million)
Table 27. Global Type-1 Diabetes Treatment Revenue Market Share by Type (2023-2032)
Table 28. Global Type-1 Diabetes Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Type-1 Diabetes Treatment Revenue Market Share by Application (2018-2023)
Table 30. Global Type-1 Diabetes Treatment Forecasted Market Size by Application (2023-2032) & (US$ Million)
Table 31. Global Type-1 Diabetes Treatment Revenue Market Share by Application (2023-2032)
Table 32. North America Type-1 Diabetes Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Type-1 Diabetes Treatment Market Size by Country (2023-2032) & (US$ Million)
Table 34. Europe Type-1 Diabetes Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Type-1 Diabetes Treatment Market Size by Country (2023-2032) & (US$ Million)
Table 36. Asia-Pacific Type-1 Diabetes Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 37. Asia-Pacific Type-1 Diabetes Treatment Market Size by Region (2023-2032) & (US$ Million)
Table 38. Latin America Type-1 Diabetes Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 39. Latin America Type-1 Diabetes Treatment Market Size by Country (2023-2032) & (US$ Million)
Table 40. Middle East & Africa Type-1 Diabetes Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 41. Middle East & Africa Type-1 Diabetes Treatment Market Size by Country (2023-2032) & (US$ Million)
Table 42. Astellas Pharma Company Detail
Table 43. Astellas Pharma Business Overview
Table 44. Astellas Pharma Type-1 Diabetes Treatment Product
Table 45. Astellas Pharma Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
Table 46. Astellas Pharma Recent Development
Table 47. Merck Company Detail
Table 48. Merck Business Overview
Table 49. Merck Type-1 Diabetes Treatment Product
Table 50. Merck Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
Table 51. Merck Recent Development
Table 52. Eli Lilly Company Detail
Table 53. Eli Lilly Business Overview
Table 54. Eli Lilly Type-1 Diabetes Treatment Product
Table 55. Eli Lilly Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
Table 56. Eli Lilly Recent Development
Table 57. Novo Nordisk Company Detail
Table 58. Novo Nordisk Business Overview
Table 59. Novo Nordisk Type-1 Diabetes Treatment Product
Table 60. Novo Nordisk Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
Table 61. Novo Nordisk Recent Development
Table 62. Sanofi Company Detail
Table 63. Sanofi Business Overview
Table 64. Sanofi Type-1 Diabetes Treatment Product
Table 65. Sanofi Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
Table 66. Sanofi Recent Development
Table 67. AstraZeneca Company Detail
Table 68. AstraZeneca Business Overview
Table 69. AstraZeneca Type-1 Diabetes Treatment Product
Table 70. AstraZeneca Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
Table 71. AstraZeneca Recent Development
Table 72. Boehringer Ingelheim GmbH Company Detail
Table 73. Boehringer Ingelheim GmbH Business Overview
Table 74. Boehringer Ingelheim GmbH Type-1 Diabetes Treatment Product
Table 75. Boehringer Ingelheim GmbH Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
Table 76. Boehringer Ingelheim GmbH Recent Development
Table 77. Novartis Company Detail
Table 78. Novartis Business Overview
Table 79. Novartis Type-1 Diabetes Treatment Product
Table 80. Novartis Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
Table 81. Novartis Recent Development
Table 82. Pfizer Inc. Company Detail
Table 83. Pfizer Inc. Business Overview
Table 84. Pfizer Inc. Type-1 Diabetes Treatment Product
Table 85. Pfizer Inc. Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
Table 86. Pfizer Inc. Recent Development
Table 87. Abbott Laboratories Company Detail
Table 88. Abbott Laboratories Business Overview
Table 89. Abbott Laboratories Type-1 Diabetes Treatment Product
Table 90. Abbott Laboratories Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
Table 91. Abbott Laboratories Recent Development
Table 92. Mannkind Corporation Company Detail
Table 93. Mannkind Corporation Business Overview
Table 94. Mannkind Corporation Type-1 Diabetes TreatmentProduct
Table 95. Mannkind Corporation Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
Table 96. Mannkind Corporation Recent Development
Table 97. Braun Melsungen AG Company Detail
Table 98. Braun Melsungen AG Business Overview
Table 99. Braun Melsungen AG Type-1 Diabetes TreatmentProduct
Table 100. Braun Melsungen AG Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
Table 101. Braun Melsungen AG Recent Development
Table 102. Macrogenics, Inc. Company Detail
Table 103. Macrogenics, Inc. Business Overview
Table 104. Macrogenics, Inc. Type-1 Diabetes TreatmentProduct
Table 105. Macrogenics, Inc. Revenue in Type-1 Diabetes Treatment Business (2018-2023) & (US$ Million)
Table 106. Macrogenics, Inc. Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Type-1 Diabetes Treatment Market Share by Type: 2022 VS 2032
Figure 2. Rapid-Acting Insulin Features
Figure 3. Short-Acting Insulin Features
Figure 4. Others Features
Figure 5. Global Type-1 Diabetes Treatment Market Share by Application in 2022 & 2032
Figure 6. Hospitals & Clinics Case Studies
Figure 7. Academic & Research Institutes Case Studies
Figure 8. Type-1 Diabetes Treatment Report Years Considered
Figure 9. Global Type-1 Diabetes Treatment Market Size (US$ Million), Year-over-Year: 2018-2032
Figure 10. Global Type-1 Diabetes Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2032
Figure 11. Global Type-1 Diabetes Treatment Market Share by Region: 2022 VS 2032
Figure 12. Global Type-1 Diabetes Treatment Market Share by Players in 2022
Figure 13. Global Top Type-1 Diabetes Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Type-1 Diabetes Treatment as of 2022)
Figure 14. The Top 10 and 5 Players Market Share by Type-1 Diabetes Treatment Revenue in 2022
Figure 15. North America Type-1 Diabetes Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 16. North America Type-1 Diabetes Treatment Market Share by Country (2018-2032)
Figure 17. United States Type-1 Diabetes Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 18. Canada Type-1 Diabetes Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 19. Europe Type-1 Diabetes Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 20. Europe Type-1 Diabetes Treatment Market Share by Country (2018-2032)
Figure 21. Germany Type-1 Diabetes Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 22. France Type-1 Diabetes Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 23. U.K. Type-1 Diabetes Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 24. Italy Type-1 Diabetes Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 25. Russia Type-1 Diabetes Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 26. Nordic Countries Type-1 Diabetes Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 27. Asia-Pacific Type-1 Diabetes Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 28. Asia-Pacific Type-1 Diabetes Treatment Market Share by Region (2018-2032)
Figure 29. China Type-1 Diabetes Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 30. Japan Type-1 Diabetes Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 31. South Korea Type-1 Diabetes Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 32. Southeast Asia Type-1 Diabetes Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 33. India Type-1 Diabetes Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 34. Australia Type-1 Diabetes Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 35. Latin America Type-1 Diabetes Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 36. Latin America Type-1 Diabetes Treatment Market Share by Country (2018-2032)
Figure 37. Mexico Type-1 Diabetes Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 38. Brazil Type-1 Diabetes Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 39. Middle East & Africa Type-1 Diabetes Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 40. Middle East & Africa Type-1 Diabetes Treatment Market Share by Country (2018-2032)
Figure 41. Turkey Type-1 Diabetes Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 42. Saudi Arabia Type-1 Diabetes Treatment Market Size YoY Growth (2018-2032) & (US$ Million)
Figure 43. Astellas Pharma Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
Figure 44. Merck Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
Figure 45. Eli Lilly Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
Figure 46. Novo Nordisk Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
Figure 47. Sanofi Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
Figure 48. AstraZeneca Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
Figure 49. Boehringer Ingelheim GmbH Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
Figure 50. Novartis Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
Figure 51. Pfizer Inc. Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
Figure 52. Abbott Laboratories Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
Figure 53. Mannkind Corporation Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
Figure 54. Braun Melsungen AG Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
Figure 55. Macrogenics, Inc. Revenue Growth Rate in Type-1 Diabetes Treatment Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Offer REPORT BUYING OPTIONS

USD GBP EURO YEN Single User Price
USD GBP EURO YEN Multi User Price
USD GBP EURO YEN Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount